Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
DOC and DHHS outline medication‑assisted treatment in prisons, cite diversion and capacity limits
Summary
Department of Health and Human Services and Utah Department of Corrections described a pilot MAT program in state prisons that continues medications for some people with opioid use disorder but currently treats only a fraction of those identified; officials cited diversion of transmucosal buprenorphine and logistical barriers to wider rollout.
Department of Health and Human Services officials told the Health and Human Services Interim Committee they are continuing medication‑assisted treatment (MAT) for people with opioid use disorder in state correctional settings while piloting delivery models to reduce diversion and preserve institutional safety. "MAT, MOUD, is a critical, evidence based component of care for individuals with opioid use disorder," said Dr. Stacy Bank, executive medical director for the department. Department clinical staff and Department of Corrections leaders described program details, funding sources and operational challenges. The department said prison health services screens every person at intake for substance use disorder and that approximately 29 percent of people entering custody meet criteria for opioid use disorder—about…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
